These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38159523)

  • 1. Prospective evaluation of MR-TRG (Tumor Regression Grade) in esophageal cancer after neo-adjuvant therapy: Preliminary results.
    Chapellier P; Fasquelle F; Saglietti C; Kinj R; Mantziari S; Schäfer M; Haefliger L; Jreige M; Vietti Violi N; Sempoux C; Dromain C
    Eur J Radiol; 2024 Feb; 171():111263. PubMed ID: 38159523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Neoadjuvant Chemoradiotherapy Response in Rectal Cancer Using MR Images and Deep Learning Neural Networks.
    Cingoz E; Ertas G; Kaval G; Azamat S; Karaman S; Kulle CB; Berker N; Cingöz M; Dagoglu Sakin N; Comert RG; Buyuk M; Kartal MGD
    Curr Med Imaging; 2024; 20():e15734056309748. PubMed ID: 38874041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma.
    Hall WA; Li J; You YN; Gollub MJ; Grajo JR; Rosen M; dePrisco G; Yothers G; Dorth JA; Rahma OE; Russell MM; Gross HM; Jacobs SA; Faller BA; George S; Al Baghdadi T; Haddock MG; Valicenti R; Hong TS; George TJ
    J Clin Oncol; 2023 Oct; 41(29):4643-4651. PubMed ID: 37478389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
    Niu S; Chen Y; Peng F; Wen J; Xiong J; Yang Z; Peng J; Bao Y; Ding L
    Front Oncol; 2023; 13():1118518. PubMed ID: 37377906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.
    Lee YD; Kim HG; Seo M; Moon SK; Park SJ; You MW
    Int J Colorectal Dis; 2024 May; 39(1):78. PubMed ID: 38789861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Mendes LST; Balyasnikova S; Evans J; Peckitt C; Begum R; Tait D; Tabernero J; Glimelius B; Roselló S; Thomas J; Oates J; Chau I
    Br J Cancer; 2017 Nov; 117(10):1478-1485. PubMed ID: 28934761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modest agreement between magnetic resonance and pathological tumor regression after neoadjuvant therapy for rectal cancer in the real world.
    Achilli P; Magistro C; Abd El Aziz MA; Calini G; Bertoglio CL; Ferrari G; Mari G; Maggioni D; Peros G; Tamburello S; Coppola E; Spinelli A; Grass F; Martin D; Hahnloser D; Salvatori A; De Simoni S; Sheedy SP; Fletcher JG; Larson DW
    Int J Cancer; 2022 Jul; 151(1):120-127. PubMed ID: 35191540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
    Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
    Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal Mucinous Adenocarcinoma: MR Imaging Assessment of Response to Concurrent Chemotherapy and Radiation Therapy-A Hypothesis-generating Study.
    Park SH; Lim JS; Lee J; Kim HY; Koom WS; Hur H; Park MS; Kim MJ; Kim H
    Radiology; 2017 Oct; 285(1):124-133. PubMed ID: 28520513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical assessment of tumor regression grade systems in gastroesophageal adenocarcinoma following neoadjuvant chemotherapy.
    Lütken C; Sheikh K; Willemoe GL; Achiam MP; Hasselby JP
    Pathol Res Pract; 2021 Aug; 224():153538. PubMed ID: 34243107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
    Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
    Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI tumour regression grade in locally recurrent rectal cancer.
    Voogt ELK; Nordkamp S; van Zoggel DMGI; Daniëls-Gooszen AW; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Cnossen JS; van Lijnschoten G; Burger JWA; Rutten HJT; Nederend J
    BJS Open; 2022 May; 6(3):. PubMed ID: 35552373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer.
    Chandramohan A; Siddiqi UM; Mittal R; Eapen A; Jesudason MR; Ram TS; Singh A; Masih D
    Eur J Radiol Open; 2020; 7():100223. PubMed ID: 32140502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of locally advanced low rectal cancer: Relationships between imaging findings and the pathological tumor regression grade.
    Fujii S; Nougaret S; Escal L; Azria D; Assenat E; Rouanet P; Reinhold C; Guiu B
    J Magn Reson Imaging; 2015 Aug; 42(2):421-6. PubMed ID: 25351373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a multiparametric MRI scoring system for histopathologic treatment response following preoperative chemoradiotherapy for rectal cancer.
    Khwaja SA; Thipphavong S; Kirsch R; Menezes RJ; Kennedy ED; Brierley JD; Jhaveri KS
    Eur J Radiol; 2021 May; 138():109628. PubMed ID: 33721764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression grade.
    Djuric-Stefanovic A; Micev M; Stojanovic-Rundic S; Pesko P; Saranovic Dj
    Eur J Radiol; 2015 Dec; 84(12):2477-84. PubMed ID: 26467704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR Imaging with Apparent Diffusion Coefficient Histogram Analysis: Evaluation of Locally Advanced Rectal Cancer after Chemotherapy and Radiation Therapy.
    Enkhbaatar NE; Inoue S; Yamamuro H; Kawada S; Miyaoka M; Nakamura N; Sadahiro S; Imai Y
    Radiology; 2018 Jul; 288(1):129-137. PubMed ID: 29558294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
    Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
    Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.